PrintyMed

Private

RigaHealthcare & Life Scienceshttps://www.printymed.com/

Last Round

Grant

Apr 28, 2026

Total Funding Raised

$1.62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PrintyMed is a biotechnology company that develops biomimetic spider silk materials for use in regenerative medicine and 3D-printed artificial organs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biomimetic spider silktissue engineeringbiomaterialsregenerative medicineorgan-on-a-chiplab-grown silkmedical implantsbiocompatible materialsdrug screeningbacterial fermentationtissue scaffoldssynthetic biologywound dressingscosmetic ingredientsbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrintyMed Comps

Public and private peers based on sector, stage, and business model.

PrintyMed comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PrintyMed Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 28, 2026
Grant	Mar 5, 2026
Accelerator	Sep 23, 2025
Grant	Oct 8, 2024
Grant	Dec 11, 2023
Pre Seed	Aug 28, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Jekaterina Romanova

Founder and CEO

Founding Team

PrintyMed Investors

Notable investors and investment history

PrintyMed investors
Investor	Rounds
European Innovation Council Fund	Grant
Confluence	Accelerator
Investment and Development Agency of Latvia	Grant, Accelerator
Health Founders	Pre Seed
Women TechEU	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 5, 2026
$86K grant received from Women TechEU

View all signals

PrintyMed Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PrintyMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PrintyMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersRiga

Employee Range3

Year Founded2023

Last FundingApr 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.